The up-regulation of RELA, AKT1, TLR1 and RAF1 and the down-regulation of MAPK9 and MAP3K8 were determined by RT-qPCR, indicating that the enhanced anti-tumor function may associate with T cell immune response and proliferation related Toll-like receptor-Akt-NF-κB signaling pathway. This evidence concerns the gene MAPK9 and neoplasm.